| dc.creator |
MUHAMMED, Muhammed Tılahun |
|
| dc.creator |
Al-Madhagi, Haitham |
|
| dc.date |
2024-09-01T00:00:00Z |
|
| dc.date.accessioned |
2025-02-25T10:20:21Z |
|
| dc.date.available |
2025-02-25T10:20:21Z |
|
| dc.identifier |
3c5b35b2-eaab-454b-ae12-f4621e0a02c3 |
|
| dc.identifier |
10.1016/j.abb.2024.110107 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/3c5b35b2-eaab-454b-ae12-f4621e0a02c3/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/99400 |
|
| dc.description |
COVID-19 is a new generation of outbreaks that invade not only local emerging region, continental but also the whole globe. Varicocele on the other hand, is a testicular vascular disease that underlies 40 % of male infertility cases. Fortunately, the two diseases can be blocked through targeting one common target, NLRP3 inflammasome. Upon searching for similar drugs that gained FDA-approval in ChEMBL library along with examining their potential blockade of the receptor through docking using CB-DOCK-2, three potential approved drugs can be repurposed, ChEMBL 4297185, ChEMBL 1201749, ChEMBL 1200545 which had binding energy of −9.8 and −9.7 kcal/mol (stronger than the reference inhibitor, −9.3 kcal/mol). Also, ADME profile of the top 3 drugs showed better attributes. Also, the simulated proteins exhibited stable pattern with strong free binding energies. Among the potential inhibitor drugs ChEMBL 4297185 was found to remain inside the binding site of the protein during the 200 ns simulation time. Hence, it is anticipated to have the highest binding and thus inhibition potential against the protein. The suggested drugs, especially ChEMBL 4297185, are potentially repurposable toward treating COVID-19 and varicocele which deserve further experimental validation. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Targeting COVID-19 and varicocele by blocking inflammasome: Ligand-based virtual screening |
|
| dc.type |
info:eu-repo/semantics/article |
|